Abstract
In the FRG the greatest portion of alcoholics only consultate a general practitioner. They often refuse further treatment although being motivated to abstain. The introduction of so-called 'anti-craving' drugs like Acamprosat offers the GPs a new therapeutic strategy. Thus, they will be confronted with the question, who should be treated with these new drugs. That's why, specialists should discuss the indications for an 'anti-craving' medication in time. According to the presented proposal 'anti-craving' drugs should be only prescribed to alcoholics clearly motivated for abstinence as well as therapy. Furthermore, they should have complained about craving in the context of relapses in the past.
| Translated title of the contribution | Indications for a treatment with 'anti-craving' drugs |
|---|---|
| Original language | German |
| Journal | Sucht |
| Volume | 42 |
| Issue number | 5 |
| Pages (from-to) | 323-330 |
| Number of pages | 8 |
| ISSN | 0939-5911 |
| Publication status | Published - 1996 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being -
SDG 10 Reduced Inequalities
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)
Fingerprint
Dive into the research topics of 'Indications for a treatment with 'anti-craving' drugs'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver